Operating CF
$1.34B
Capex
−$369.00M
Free Cash Flow
$972.40M
FCF Margin
+72.5%
Cash flow waterfall for STERIS (STE) — TTM through Q1 2026
Free cash flow: $972.40M
Cash flow breakdown for STERIS (STE) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.34B | $1.34B |
| Capital Expenditure | −$369.00M | $972.40M |
| Free Cash Flow | $972.40M | $972.40M |
| Other Investing | −$143.50M | $828.90M |
| Share Buybacks | −$114.10M | $714.80M |
| Dividends Paid | −$241.80M | $473.00M |
| Net Debt Change | −$159.80M | $313.20M |
| Other Financing & FX | −$45.30M | $267.90M |
| Net Cash Increase | $267.90M | $267.90M |
- Operating Cash Flow$1.34B
- Capital Expenditure−$369.00M
- Free Cash Flow$972.40M
- Other Investing−$143.50M
- Share Buybacks−$114.10M
- Dividends Paid−$241.80M
- Net Debt Change−$159.80M
- Other Financing & FX−$45.30M
- Net Cash Increase$267.90M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
STERIS (STE) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement